01 6Olumiant
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 639
2019 Revenue in Millions : 427
Growth (%) : 50
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 1,115
2020 Revenue in Millions : 639
Growth (%) : 75
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 831
2021 Revenue in Millions : 1,115
Growth (%) : -26
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 923
2022 Revenue in Millions : 831
Growth (%) : 11
Main Therapeutic Indication : Immunology
Currency : USD
2024 Revenue in Millions : 957
2023 Revenue in Millions : 923
Growth (%) : 4
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 427
2018 Revenue in Millions : 203
Growth (%) : 111
